Starling Oncology, Inc. (STLNW) balance sheet

STLNWNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLN

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30

$0.03+0.00 (+10.87%)

Close on Oct 30, 2026Market cap $665.51MP/E –Yield –

Starling Oncology, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Cash & Equivalents	34	50	33	14	115	6.00	2.45
Short-Term Investments	–	0	49	60	0	–	–
Cash & Short-Term Investments	34	50	83	74	115	6.00	2.45
Receivables	59	48	42	40	20	17	–
Inventory	17	10	14	9.26	6.44	4.35	–
Prepaid Expenses & Other	2.99	4.03	4.05	6.92	11	2.11	–
Total Current Assets	113	112	143	130	154	30	0.03
Property, Plant & Equipment	11	12	11	8.55	4.19	2.10	–
Accumulated Depreciation	-11	-6.97	-6.18	-3.51	-1.98	-1.16	–
Long-Term Investments	–	–	0	58	0	–	–
Operating Lease Right-of-Use Assets	22	26	29	24	0	–	–
Goodwill	7.23	7.23	7.23	21	27	14	–
Intangible Assets	11	15	18	18	18	20	–
Other Long-Term Assets	0.61	0.59	0.56	0.48	0.32	0.12	–
Total Assets	165	173	209	262	203	66	0.05
Accounts Payable	43	24	14	9.37	16	13	–
Accrued Expenses	21	21	14	15	14	9.45	0.03
Current Portion of Long-Term Debt	–	–	–	0	0.18	5.37	–
Current Debt	–	–	–	0	0.18	5.37	–
Current Portion of Leases	7.16	6.80	6.36	5.50	0	–	–
Current Income Taxes Payable	–	–	0	0.26	0.13	1.14	–
Deferred Revenue (Current)	2.28	2.35	0.55	1.14	0.26	–	–
Other Current Liabilities	21	21	14	15	14	9.45	–
Total Current Liabilities	71	52	35	30	30	29	0.03
Long-Term Debt	77	93	87	81	0	6.56	–
Long-Term Leases	19	23	26	22	0	–	–
Operating Lease Liabilities	26	30	33	28	0	–	–
Deferred Tax Liabilities	0	0.03	0.03	0.11	0.37	1.61	–
Other Long-Term Liabilities	0.03	0.13	0.37	0.87	6.90	0.81	–
Total Liabilities	180	169	152	138	99	38	0.03
Total Debt	77	93	87	81	0.18	12	–
Preferred Stock	0	0	0	0	0	0	–
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	–
Additional Paid-In Capital	257	215	204	186	167	80	0.02
Retained Earnings	-271	-211	-146	-63	-63	-52	0.00
Treasury Stock	-1.02	-1.02	-1.02	0	–	–	–
Shareholders' Equity	-16	3.59	57	123	104	28	42
Total Equity	-16	3.59	57	123	104	28	42
Total Liabilities & Equity	165	173	209	262	203	66	0.05
Shares Outstanding(shares)	99	76	74	73	73	23	5.75

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -4.4%
Net margin: -6.2%
Return on equity, FY2025: 999.2%

Financial strength

Current ratio: 1.36
Debt to equity: -3.21
Debt to assets: 44.8%
Cash to current liabilities: 43.3%

Valuation

P/E ratio: –
Price to sales: 1.13
Price to book: –
Dividend yield: –